Naomi Hannaway

8PUBLICATIONS
18CO-AUTHORS
Medical infection agents (incl. prions)Neurology and neuromuscular diseasesEnglish languageHistorical, comparative and typological linguisticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 25, 2026
Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases.

|Nov 25, 2025
Evidence for divergent cortical organisation in Parkinson's disease and Lewy Body Dementia.

Angeliki Zarkali, George Thomas, Naomi Hannaway

|Sep 04, 2025
Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia.

Rohan Bhome, George E C Thomas, Naomi Hannaway

|Aug 07, 2025
Reply: Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes.

Naomi Hannaway, Angeliki Zarkali, Rohan Bhome

|May 22, 2025
Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes.

Naomi Hannaway, Angeliki Zarkali, Rohan Bhome

|May 02, 2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.

Roger A Barker, Nicholas P Lao-Kaim, Natalie Valle Guzman

Pageof 2

Frequent Collaborators

5 joint publications

Rimona Sharon Weil

4 joint publications

Angeliki Zarkali

2 joint publications

Ivelina Dobreva

2 joint publications

George Thomas